Jasper Therapeutics (JSPR) awards 7,500 stock options to board director
Rhea-AI Filing Summary
Jasper Therapeutics, Inc. reported that director Kurt Von Emster received a grant of stock options covering 7,500 shares of Voting Common Stock at an exercise price of $0.6300 per share. The options were granted automatically under the Non-Employee Director Compensation Policy, vest on July 31, 2027, and expire on July 31, 2036.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
EMSTER KURT VON
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy F1 | 7,500 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (Right to Buy — 7,500 shares (Direct)
Footnotes (1)
- F1. Granted automatically pursuant to the Issuer's Non-Employee Director Compensation Policy, which provides that non-employee directors are automatically granted an option to purchase 7,500 shares on the date of each of the Issuer's annual meeting of stockholders, which shall vest in full upon the first anniversary of the date of the grant, subject to the director's continued service through such vesting date.
Key Figures
Stock options granted: 7500.0000 options
Exercise price: $0.6300 per share
Vesting date: July 31, 2027
+2 more
5 metrics
Stock options granted
7500.0000 options
Grant to director Kurt Von Emster on July 31, 2026
Exercise price
$0.6300 per share
Exercise price for the granted stock options
Vesting date
July 31, 2027
Options vest in full on the first anniversary of grant
Expiration date
July 31, 2036
Reported expiration date for the granted options
Derivative holdings after grant
7500.0000 options
Total stock options held after the reported transaction
Key Terms
Non-Employee Director Compensation Policy, stock option, vesting, conversion_or_exercise_price
4 terms
Non-Employee Director Compensation Policy financial
"Granted automatically pursuant to the Issuer's Non-Employee Director Compensation Policy"
stock option financial
"non-employee directors are automatically granted an option to purchase 7,500 shares"
A stock option is a contract that gives you the right to buy or sell a company's stock at a specific price within a certain time frame. People use them to potentially make money if the stock's price moves favorably or to protect against losses. It's like holding a coupon that can be used to buy or sell stock at a set price later on.
vesting financial
"which shall vest in full upon the first anniversary of the date of the grant"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
conversion_or_exercise_price financial
"conversion_or_exercise_price of 0.6300 for the stock option grant"
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What stock options were granted to Jasper Therapeutics (JSPR) director Kurt Von Emster?
Kurt Von Emster received a grant of stock options for 7,500 shares of Voting Common Stock. These were reported as a derivative award, increasing his post-transaction holdings to 7,500.0000 options linked to Jasper Therapeutics shares.
What is the exercise price of the new JSPR director stock options?
The granted options carry an exercise price of $0.6300 per share. This price applies to each of the 7,500 underlying shares of Voting Common Stock that may be purchased upon exercise of the options.
When do Kurt Von Emster's new Jasper Therapeutics (JSPR) options vest and expire?
The options are scheduled to vest in full on July 31, 2027, the first anniversary of the grant date. They are reported to expire on July 31, 2036, if not exercised earlier in accordance with their terms.
Under what policy were the JSPR director stock options granted?
The options were granted automatically under Jasper Therapeutics’ Non-Employee Director Compensation Policy. This policy provides that non-employee directors receive an option to purchase 7,500 shares on each annual meeting date, subject to service-based vesting.
Were the new JSPR director options granted under a Rule 10b5-1 trading plan?
The filing indicates the Rule 10b5-1 checkbox is not marked as a plan transaction. The grant instead arises automatically from the company’s Non-Employee Director Compensation Policy tied to the annual meeting of stockholders.